|
⚲
|
| Novelos Therapeutics Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001279704 |
| Sale | 2009-08-25 ($9.0 M Offered, $9.0 M Sold) |
| Fund | |
| Phone | 6172441616 |
| Address | One Gateway Center, Suite 504 Newton, 02458 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| David McWilliams | |
| Howard Schneider | |
| Simm Fass | |
| Joanne Protano | |
| Christopher Pazoles | |
| Elias Nyberg | |
| Michael Doyle | |
| James Manuso | |
| Kristin Schuhwerk | |
| Harry Palmin | |
| Stephen Hill |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
TM Meadows Associates LLC
✚
|
0.0 | |
|
TMP Edwards Partners I LLC
✚
|
0.0 | |
|
to Capital LLC
✚
|
0.0 | |
|
Toftegaard Claus
✚
|
0.0 | |
|
TO Fund I, a series of MV Funds, LP
✚
|
0.0 | |
|
TOG Delaware, LLC
✚
|
0.0 | |
|
Tola Capital Partners II, LP
✚
|
0.0 | |
|
Tolerion, Inc.
✚
|
0.0 | |
|
Tolko Industries Ltd.
✚
|
0.0 | |
|
TML SPV a Series of CGF2021 LLC
✚
|
0.0 |